GE HealthCare will unveil its latest innovation at the 2025 Annual Meeting of the International Society for Magnetic Resonance in Medicine in Honolulu, Hawaii. Featuring technology and designs that will open new frontiers in diagnostic and research imaging, SIGNA™ Sprint‡ delivers unparalleled gradient performance at 1.5T to enable a leap forward in key clinical areas, including cardiology and oncology.
In cardiology, the 1.5T field strength ensures the broadest populations of patients can be imaged. Coupled with cutting-edge deep-learning technology like Sonic DL™ for Cine, SIGNA Sprint is designed to aid in standardization in quantitative Cardiac MR. In oncology, SIGNA Sprint seeks to enable earlier disease detection and treatment response through exceptional diffusion imaging, not previously thought possible at 1.5T. Radiotherapy and radiation oncology users will appreciate the advanced gradient technology that is designed to enable precision targeting and treatment planning using new deep-learning techniques for improving diffusion image quality.
At its core, SIGNA Sprint is designed to provide exceptional power with brilliant intelligence. Tools like Imaging 360 and other clinical efficiency technologies deliver a brilliant experience for users of all levels. Foundational to SIGNA Sprint is patient satisfaction, prioritizing comfort. Our teams look forward to sharing SIGNA Sprint with the world — and sharing our journey as we take MR to places it’s never been before.
‡ SIGNA Sprint is 510(k) pending with the USA FDA. Not CE Marked. Not available in all regions.
Continue Reading
The power to explore further
Volume 38 — Spring 2025
Published
AI synergistically transforms the MR experience
Published
Join us in seeing the future of MR
Published
How we are fueling further exploration for clinicians and scientists
Published
In partnership with EU consortium, GE HealthCare to advance AI in healthcare through synthetic data
Published
PREDICTOM launches prospective study, gears up for MR protocol harmonization
Published
First modular MR in Southeast Asia
Published
ISMRM 2025 abstracts
Published
MR neurography imaging for all: providing a new service line using existing sequences and systems
Published
Progardia lowers energy consumption, reduces carbon footprint and increases image quality with continued investment in MR and AI
Published
Life-speed imaging with Sonic DL Cine opens up cardiac MR access to those who need it most
Published
Elevating neuro imaging with an upgrade to SIGNA PET/MR
By Ju-Chieh Kevin Cheng, PhD, UBC PET/MRI Physicist, Research Scientist at UBC Pacific Parkinson’s Research Centre, Vesna Sossi, PhD, Professor, Department of Physics and Astronomy, Adjunct Professor at Djavad Mowafaghian Centre for Brain Health, and Elham Shahinfard, PhD, PET-MR Imaging Program Manager, Charles E. Fipke Integrated Neuroimaging Suite, The University of British Columbia, Vancouver, British Columbia, Canada
Published
Advancing women’s imaging through collaboration
Published
The role of deep-learning T2 PROPELLER, diffusion and perfusion sequences in 3.0T MR evaluation of head-neck tumors
By Simona Marzi, PhD, medical physicist, Michele Farella, technologist, Giovanni Di Giulio, technologist, and Antonello Vidiri, MD, Medical Director, Regina Elena National Cancer Institute, Rome, Italy
Published
Leading the way in breast and pelvic imaging with SIGNA Hero
By Shunsuke Matsumoto, MD, Radiology Manager, Keiyu Hospital, Yokohama, Japan
Published
Shorter scan times and higher quality imaging reduce the need for sedation in pediatric patients
By Pär-Arne Svensson, BSc, Research Radiographer MRI, and Liz Ivarsson, MD, Senior Consultant and Pediatric Radiologist, Queen Silvia Children’s Hospital, Gothenburg, Sweden
Published
Enhancing surgical precision and patient outcomes with fMRI
By Yoshiyuki Watanabe, MD, PhD, Professor, Department of Radiology, Shiga University of Medical Science, Ōtsu, Shiga, Japan
Published
Bringing AIR Recon DL to multi-shot diffusion
By Patricia Lan, PhD, MR Scientist, Arnaud Guidon, PhD, Director of Body & Oncology MR, and Suryanarayanan “Shiv” Kauskik, PhD, Senior Digital Product Manager, GE HealthCare
Published
Ultra-high contrast MR of the brain and spinal cord
By Paul Condron, BSc (Hons), MRI Charge Technologist, Mark Bydder, PhD, Senior Research Fellow, Samantha J. Holdsworth, PhD, Executive Director at Mātai Medical Research Institute and Associate Professor at the University of Auckland, Daniel M. Cornfeld, MD, FRANZCR, Clinical Lead, and Graeme M. Bydder, FRANZCR, Scientific Advisory Board Member, Mātai Medical Research Institute, Gisborne, New Zealand
Published
Deuterium metabolic imaging shows promise in detecting Alzheimer’s disease
Published